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ABSTRACT
Contraception may provide a useful nonlethal management tool when it is desirable to reduce
populations of birds. We tested the efficacy of 20,25 diazacholesterol, and immunization with
avian gonadotropin-releasing hormone (AGnRH-I) and chicken riboflavin carrier protein (cRCP)
as contraceptives and investigated their modes of action in Coturnix quail (Coturnix coturnix
japonica). Females that were paired with males treated with 20,25 diazacholesterol produced
lower percentages of eggs that were fertile and hatched. Females treated with 20,25
diazacholesterol and paired with control males laid fewer eggs, and lower percentages of their
eggs were fertile and hatched. Treatment with 20,25 diazacholesterol reduced testosterone
levels in males and progesterone levels in females. Nonesterified cholesterol levels were
reduced, whereas desmosterol levels increased in birds treated with 20,25 diazacholesterol.
Treatment with AGnRH-I and cRCP immunocontraceptive vaccines did not decrease average
egg production and hatchability or hormone levels, but this failure might have been due to the
vaccination protocol. If registered, wildlife managers may be able to use 20,25 diazacholesterol
when other methods, such as lethal control, are undesirable for reducing damage caused by
specific breeding behaviors such as the building of nests.
(Key Words: avian gonadotropin-releasing hormone, chicken riboflavin carrier protein, 20,25
diazacholesterol, immunocontraception, reproductive inhibition)
2004 Poultry Science 83:234-244
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ABSTRACT Contraception may provide a useful nonlethal management tool when it is desirable to reduce populations of birds. We tested the efficacy of 20,25
diazacholesterol, and immunization with avian gonadotropin-releasing hormone (AGnRH-I)and chicken riboflavin carrier protein (cRCP) as contraceptives and
investigated their modes of action in Coturnix quail (Coturnix coturnix japonica). Females that were paired with
males treated with 20,25 diazacholesterol produced lower
percentages of eggs that were fertile and hatched. Females
treated with 20,25 diazacholesterol and paired with control males laid fewer eggs, and lower percentages of their

eggs were fertile and hatched. Treatment with 20,25 diazacholesterol reduced testosterone levels in males and
progesterone levels in females. Nonesterified cholesterol
levels were reduced, whereas desmosterol levels increased in birds treated with 20,25 diazacholesterol. Treatment with AGnRH-I and cRCP immunocontraceptive
vaccines did not decrease average egg production and
hatchability or hormone levels, but this failure might have
been due to the vaccination protocol. If registered, wildlife
managers may be able to use 20,25 diazacholesterol when
other methods, such as lethal control, are undesirable for
reducing damage caused by specific breeding behaviors
such as the building of nests.
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INTRODUCTION
Birds cause numerous conflicts including consumption
of food crops (White et al., 1985; Dolbeer et al., 1986;
Wilson et al., 1989), fruits and vegetables (Clark, 1986),
livestock feed (Glahn, 1982; Glahn and Otis, 1986), and
fish at aquaculture facilities (Parkhurst et al., 1987; Stickley et al., 1995; Andelt et al., 1997).Birds also cause public
health concerns by transmitting disease (Gough and
Beyer, 1982; Glahn and Stone, 1984) and safety concerns
by striking aircraft (Dolbeer, 1989; Conover et al., 1995).
Care must be taken in selecting and using techniques that
resolve conflicts because the public has concern about
lethal control techniques. Contraception is a possible nonlethal alternative that is more acceptable to the general
public than lethal control measures (Arthur, 1981; Messmer et al., 1997; Stout et al., 1997).
A number of contraceptives have been tested in birds,
but several, such as the synthetic estrogen BDH10131
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(Kendle et al., 1973),mestranol (Wentworth, 1968; Wentworth et al., 1968; Sturtevant, 1970),a-chlorohydrin (Aire
and Olusanya, 1980),triethylenemelamine (TEM) (Davis,
1961; Vandenbergh and Davis, 1962; Messersmith, 1971;
Bhat and Maiti, 1989), thiotepa (Potvin et al., 1982), and
surgical sterilization (Converse and Kennelly, 1994),have
produced unacceptable results. The desirable qualities of
any wildlife contraceptive are that it last for one breeding
season with a minimal number of days of treatment and
that it be reversible so as not to permanently remove the
animals from the gene pool. In addition, for practical
reasons, the contraceptive should be oral to eliminate the
need to capture animals and must be relatively inexpensive (Turner and Kirkpatrick, 1991;Garrott, 1995).Mestranol, a-chlorohydrin, and TEM might possibly
permanently sterilize adults and young being fed by crop
milk. Thiotepa and BDH10131 are associated with a limited duration of effect that requires an extended treatment

Abbreviation Key: AGnRH-I = avian gonadotropin-releasing hormone; cRCP = chicken riboflavin carrier protein; FCA = Freund's complete adjuvant; FIA = Freund's incomplete adjuvant; FSH = folliclestimulating hormone; GnRH = gonadotropin-releasing hormone; KLH =
keyhole limpet hemocyanin; LH = luteinizing hormone; TEM = triethylenemelamine.
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period to cover the breeding season. Surgical sterilization
is prohibitively expensive.
The cholesterol inhibitor 20,25 diazacholesterol is a
promising contraceptive because, in contrast to immunocontraceptives that currently must be injected, it can be
delivered orally. Research on the efficacy of 20,25 diazacholesterol produced conflicting results with red-winged
blackbirds (Agclauis plzoetzice~rs) (Fringer and Granett,
1970; Lacombe et al., 1986, 1987, 1990), pigeons (Columba
liuia) (Schortemeyer and Beckwith, 1970; Sturtevant and
Wentworth, 1970), house sparrows (Passer doniesticus)
(Sanders and Elder, 1976; Mitchell et al., 1979), grackles
(Quiscallls quisctrla) (Fringer and Granett, 1970), Japanese
quail (Coturnix coturnix japonica), and parakeets (probably
Melopsittacus trndlrlatus) (Powell, 1966).Conclusions from
these studies were limited because little physiological
work with hormone levels was conducted to determine
the mode of action of the compound.
Immunocontraception acts on the animal's immune
system to control reproduction. Gonadotropin-releasing
hormone (GnRH) is a promising antigen for use as an
immunocontraceptive vaccine. Antibodies generated
against avian GnRH (AGnRH-I) or GnRH were effective
in inhibiting reproduction in cowbirds (Molotlzrt~satev;
Thompson et al., 1994), starlings (L. A. Miller, 2000,
USDA/APHIS/WS/NWRC, personal communication),
and several species of mammals (Ladd et al., 1988; Awoniyi et al., 1993; Meloen et al., 1994). The amino acid sequence of AGnRH-I differs from mammalian GnRH by
one amino acid, which may confer some avian specificity.
Mammalian GnRH vaccines were effective for 2 1 yr in
rats (Rattus noruecyictrs) (Miller et al., 1997) and 2 2 yr in
white-tailed deer (Odocoilet~svircyinianus) (Miller et a].,
2000), which may make AGnRH-I suitable for use as an
immunocontraceptive lasting at least one breeding season
in birds.
Another promising antigen for use in an immunocontraceptive vaccine is chicken riboflavin carrier protein
(cRCP).Antibodies to cRCP inhibited reproduction in lab
mice (inbred Swiss strain; Natraj et al., 1994) and common
marmosets (Cnllithrixjaccllus; Natraj, 1991). Immunological homologues to cRCP were demonstrated in lab mice
and rats (Muniyappa and Adiga, 1980; Natraj et al., 1987),
primates (Mncaca rarliata; Visweswariah and Adiga, 1987a;
Callitllrix jacdlus; Natraj and Kholkute, 1989),and humans
(Natraj et al., 1987; Visweswariah and Adiga, 1987%).A
cRCP vaccine may be preferable to other contraceptive
agents because it should not interfere with reproductive
and territorial behaviors. No research has previously been
conducted to test the effect of antibodies to cRCP on
reproduction of birds.
Our objectives were to assess the efficacy of 20,25 diazacholesterol and immunization with AGnRH-I-keyhole
limpet hemocyanin (KLH) and cRCP-KLH in Coturnix
quail by measuring numbers of eggs produced, fertility,
and hatchability of eggs. Our objectives also were to document the effects of all 3 contraceptives on testosterone and
progesterone levels; the effect of 20,25 diazacholesterol on
cholesterol, desmosterol, and corticosterone levels; the
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effect of AGnRH-I on corticosterone levels; and the ability
of AGnRH-I and cRCP to induce an antibody response.
We proposed that 20,25 diazacholesterol would reduce
fertility by preventing side chain cleavage of cholesterol
or reduce cholesterol levels directly by preventing the
conversion of desmosterol to cholesterol (Dietert and Scallen, 1969; Counsel1 et al., 1971; Emmons et al., 1982).
Cholesterol is the parent compound for steroid hormones,
which include the reproductive hormones testosterone
and progesterone. We hypothesized that the block of desmosterol to cholesterol would result in increased desmosterol and decreased cholesterol and, therefore,
decreased testosterone, progesterone, and corticosterone,
thus reducing egg production and fertility.
We proposed that vaccination with AGnRH-I vaccine
would create antibodies to native AGnRH-I. In the male,
treatment with AGnRH-I should indirectly lower testosterone levels through its effect on follicle-stimulating hormone (FSH)and luteinizing hormone (LH),thus lowering
sperm prndi~rtionand red~icingfertility and hatchability.
In females, treatment with AGnRH-I should lower FSH
and LH levels, reducing follicular development, thus indirectly reducing progesterone levels and egg production.
Because the AGnRH-I vaccine may affect copulatory behavior, we predicted that treated females might lay a
lower percentage of fertile eggs. In birds, corticosterone is
formed from progesterone, thus we predicted decreased
progesterone could also decrease corticosterone. We did
not expect a reduction in testosterone to have any effect
on corticosterone levels.
We proposed that vaccination with cRCP vaccine
would create antibodies to native cRCP, thus blocking
riboflavin binding to the riboflavin transport protein and
preventing storage of riboflavin. We proposed this block
would cause embryos of treated birds to consistently die
at an early stage because riboflavin is essential for embryonic development, and so a lower percentage of eggs
would hatch in the treated group than in the control
group. We predicted that treatment would have no effect
on progesterone levels and therefore would not affect the
number or fertility of eggs laid by treated females.
Coturnix quail were used in this study because, in contrast to many wild species of birds, Coturnix quail reproduce readily in captivity, and their reproductive cycles are
easily manipulated by changing the photoperiod (Padgett
and Ivey, 1959; Wilson et al., 1962; Schafer et al., 1977).
Testicular regression can be induced using a 6L:18D light
cycle, and testicular development can be induced using
a 16L:BD light cycle (Schafer et al., 1977).Egg production
can be reduced by decreasing the number of hours of
light exposure (Wilson et al., 1962). Coturnix quail are
sexually mature at 42 d, and mature females can lay I
300 eggs per year in the laboratory (National Academy
of Sciences, 1969). Coturnix quail exhibit reproductive
seasonality in natural settings (National Academy of Sciences, 1969; Wada, 1979).Once the male is removed from
the female, sperm can be stored and is viable in the female
reproductive tract for 6 to 9 d (Sittman and Abplanalp,
1965; Woodard and Abplanalp, 1967).
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MATERIALS AND METHODS
The experimental protocol was reviewed by the Colorado State University and National Wildlife Research
Center's Animal Care and Use Committees and complied
with the Animal Welfare Act. The experiment consisted
of 1) 20 female Coturnix quail treated with 20,25 diazacholesterol%nd paired with 20 untreated males, 2) 20
males treated with 20,25 diazacholesterol and paired with
20 untreated females, 3) 20 females vaccinated with
AGnRH-I-KLH and paired with 20 untreated males, 4)
20 males vaccinated with AGnRH-I-KLH and paired with
20 untreated females, 5) 20 females vaccinated with cRCPKLH and paired with 20 untreated males, and 6) a control
group of 20 untreated males paired with 20 untreated
females. The untreated members of each group were used
to provide fertility and hatching data. Birds were weighed
and separated by sex. Six of the heaviest of 120 females
were randomly assigned to each of 6 treatment groups,
then the next 6 heaviest females were randomly assigned
to groups, and so on until each group contained 20 females. The same procedure was used for the males. Ten
birds of each sex from each treatment group were randomly assigned to each of 2 experimental rooms. Birds
within treatment groups were then randomly assigned
to pairs. Pairs of birds from the same treatment groups
were randomly assigned to cage racks and to cages within
racks. All birds were 8 wk of age at the beginning of the
study (at pretreatment wk 1).Birds were maintained on
a 16L:8Dlight cycle, which we determined in a pilot study
to be the optimal light cycle for peak sex hormone levels
(Yoder, 2000). Quail were maintained on a layer diet9hat
consisted of 3.6 to 4.6% calcium, 2 0.5'%)phosphorus, 2
l6'%crude protein, and 2.88 kcal/g metabolizable energy.
We drew 500 /IL of blood from the jugular vein of
each bird treated with 20,25 diazacholesterol and from
all control birds once each week for 3 wk pretreatment
(at 8, 9, and 10 wk of age), once per week for 2 wk of
treatment (at 11 and 12 wk of age) and 8 wk posttreatment
(at 13 to 21 wk of age), and then once every 2 wk for 11
wk. We drew 500 /tL of blood from the jugular vein of
AGnRH-I- and cRCP-treated birds once each week for 3
wk pretreatment (at 8,9, and 10 wk of age); once each in
wk 7 (at 14 wk of age), wk 11 (at 18 wk of age), and wk
13 (at 20 wk of age); and then once every 2 wk for 11 wk.
Birds in the AGnRH-I and cRCP groups were held as if
for bleeding, but no blood was drawn during wk 4, 5, 6,
8, 9, 10, and 12. Females were bled starting at 1300 h,
which was pre\liously determined in a pilot study to be
when peak progesterone levels occurred (Yoder, 2000).
The 500 /IL of blood represents < l'X1 of body ~reiglitor
5 3.5%)standing blood volume. We be1ieL.e this removal
of blood did not ad\rersely affect the birds because starling
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chicks (Clark, 1991)and adult pigeons (Kovach and Szasz,
1968) survived daily blood losses of approximately 20 to
85'% of the standing blood volume (7%) of body
weight), respectively.
Immediately following the 3-wk pretreatment, all females scheduled for treatment were randomly assigned
to males scheduled for treatment; all females scheduled
to be untreated were randomly assigned to males scheduled to be untreated, and control birds were randomly
rearranged in pairs. Pairs were caged together (one female
and one male per cage) and fed treated or control bait.
This rearrangement of pairs was necessary to feed treated
bait because of space limitations. At the end of treatment,
birds were returned to their original pair groups. Quail
in the AGnRH-I and cRCP groups were maintained on
Purina game bird layer ration. Quail in the 20,25 diazacholesterol group were maintained on the same diet except for the addition of 20,25 diazacholesterol to the feed
during the treatment period.
We formulated bait to contain 0.l0X 20,25 diazacholesterol by weight of total dry feed because Elder (1964) and
Woulfe (1967) reported that concentrations lower than
0.l0/o were ineffective, and higher concentrations produced signs of mild toxicity. We created a mash using
water and the pelleted food normally fed and then mixed
in the 20,25 diazacholesterol. Woulfe (1967) reported that
20,25 diazacholesterol was effective when fed to birds for
5 d, and he did not recommend feeding for >16 d due to
toxic effects. We fed the treated mash to quail in the 20,25
diazacholesterol group, as the sole source of food, for 14
d during wk 4 and 5 to 50% of the birds in treatment
groups, but because they exhibited signs of toxicity, we
fed the remaining 25 and 25% of the birds for 13 and 12
d, respectively. This procedure resulted in 10 males and
10 females fed treated bait for 14 d, 5 males and 5 females
fed treated bait for 13 d, and 5 males and 5 females fed
treated bait for 12 d. Data were combined regardless of
the length of treatment for analysis. Control birds were
fed the same product without the 20,25 diazacholesterol.
Uneaten bait was weighed each day. We calculated the
average dose of 20,25 diazacholesterol fed to each bird
each day post hoc as described in Yoder (2000). Quail
were weighed once a week during the treatment period
and once every 2 wk thereafter to ascertain if weight
loss occurred.
Primary and booster AG~RH-1'and cRCp4 vaccines
were prepared according to the method described by the
manufacturer for maleimide-activated keyhole limpet hemocyanin ( K L H ) .In
~ wk 3, birds in the AGnRH-I treatment group were given a 0.3-mL primary vaccination of
100 /lg of AGnRH-I-KLH conjugate in Freund's complete
adjuvant (FCA)," and cRCP birds were given a 0.3-mL
primary l~accinationof 100 /rg of cRCP-KLH conjugate in
FCA. Two 0.3-mL booster vaccinations consisting of 100
/ ~ of
g AGnRH-I-KLH conjugate in Freund's incomplete
adjuvant (FIA)"or 100 11gof cRCP-KLH conjugate in FIA
were gilnen to the respective groups during wk 7 and 11.
Control birds were sham vaccinated with 0.15 mL of saline in 0.15 mL of FCA or FIA. Vaccinations were given

IMMUNOCONTRACEPTIVES AND 20,25 DIAZACHOLESTEROL
subcutaneously in 4 areas of the breast. Quail were
weighed once every 2 wk to ascertain if weight loss occurred.
Because sperm can remain viable in the reproductive
tract of female quail for 5 9 d (Sittman and Abplanalp,
1965; Woodard and Abplanalp, 1967), we did not begin
collecting eggs to determine fertility and hatchability for
the 20,25 diazacholesterol groups until 1 wk after treatment ceased due to the necessary rearrangement of pairs
for treatment purposes. We did not expect any effects on
fertility and hatchability from the AGnRH-I and cRCP
vaccines until 2 2 wk after the last booster vaccine was
given, thus we began collecting eggs 3 wk after the last
vaccination. Eggs were collected and incubated to determine viability of the embryos and chicks. Unhatched eggs
were opened after the expected hatching date to determine fertility. The stage of development of the embryo
at death was determined for the cRCP and control groups
only according to Padgett and Ivey (1960). Fertility was
defined as the presence of an embryo or a blastodisc.
Eggs were considered to be infertile if neither an embryo
nor a blastodisc could be located or the egg had degraded
to the point that such a determination was not possible.
We determined plasma progesterone, testosterone, and
corticosterone levels for all treatment and control groups
using a solid-phase I ' RIA
~ ~ technique with antibodycoated tubes7 and a Genesys 5000 series multiwell ? ~ o u n t e rDesmosterol
.~
and nonesterified cholesterol levels were determined for the 20,25 diazacholesterol groups
using HPLC following the procedure of Johnston et al.
(2001). Antibody titer levels were determined for the
AGnRH-I and cRCP groups using an ELISA technique
developed at the National Wildlife Research Center
(Yoder, 2000).

Statistical Analyses
We divided the study into pretreatment (1 to 3 wk)
and treatment and posttreatment (4 to 23 wk) phases for
comparisons among diazacholesterol and control groups.
Data were combined for the diazacholesterol groups regardless of the length of treatment. We also divided the
study into pretreatment (1 to 3 wk), priming (4 to 7 wk),
first boost (8 to 11 wk), and second boost (12 to 24 wk)
phases for comparisons among AGnRH-I, cRCP, and control groups. We used a one-way ANOVA (PROC GLM;
SAS Institute Inc., 1988), and P < 0.05 for all analyses.
The mean percentage of fertile eggs was calculated by
combining the number of eggs that hatched and the number of eggs that were fertile (either by the presence of
an embryo or blastodisc) post expected hatching date,
dividing this number by the total number of eggs set,
and multiplying the result by 100. The mean number of
eggs that hatched was calculated by diiriding the number

Product numbers TKPG1, TKTT1, and TKRCI, respectively, Diagnostic Products Corp., Los Angeles, CA.
'Laboratory Technologies lnc., Schaumburg, IL.
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-Control - - DiazaCon

Week of study
FIGURE 1. Fertility of eggs laid by 20 untreated female Coturnix quail
paired with 20 males treated w t h 20,25 diazacholesterol (DiazaCon)
compared with eggs of 20 untreated female quail paired wit11 20 male
controls at the National Wildlife Research Center, Fort Collins, Colorado,
January to July 1997. Note that quail were 12 wk of age during treatment
w k 4. LSD = least significant difference.

of eggs that hatched by the number of eggs set and multiplying the result by 100.We divided the incubation period
into 6 stages of embryonic development, incubation 1 to
3 d, 3 to 6 d, 6 to 9 d, 9 to 12 d, 12 to 15 d, and 15 to 17
d, and assigned each embryo to a stage of development
at death. We compared average stage of development at
death among the cRCP and control groups using a onetailed ANOVA. Only weeks that eggs were incubated to
term were used for this analysis.
Because pretreatment levels of testosterone and corticosterone varied among birds, we averaged the 3 pretreatment values for each bird, subtracted this value from the
response mean of 4 to 23 wk by bird for the diazacholesterol and control group comparisons and from the mean
of each of the subsequent phases for AGnRH-I, cRCP,
and control group comparisons. We compared the testosterone differences among treatment and control groups,
and the corticosterone differences among the control and
20,25 diazacholesterol groups and among the control and
female AGnRH-I groups using a one-tailed or twotailed ANOVA.

-Control - - DiazaCon - female

Week of study
FIGURE 2. Egg production of 20 female Coturnix quail treated ~aitli
20,25 diazacholesterol (DiazaCon) and 20 female control quail at the
National Wildlife Research Center, Fort Collins, Colorado, January to
July 1997. Note that qua11 Ivere 12 ~ v kof age during treatment \vk 1.
LSD = least significant difference.
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TABLE 1. Fertility, hormone, cholesterol, and desmosterol levels and weight for males treated
with 20,25 diazacholesterol and control Coturnix quail at the National Wildlife
Research Center, Fort Collins, Colorado, January to July 1997
20,25 Diazacholesterol
n

-

x

SE

Control
n

-

x

SE

-

P'
-

I'ercentage of fertile eggs2
Percentage of eggs hatched'
Change in testosterone ( ~ ~ g / r n L ) ' , ~
Nonesterified cholesterol (icg/mL)
Desmosterol (/cg/mL)
Change in bodv weight (g)7,'

17
17
20
17
17
20

42.0
23.0
-0.95
203.79
232.59
6.00

6.0
4.0
0.27
21 . I 1
40.58
3.39

20
20
20
19
19
20

71.0
37.0
0.13
331.43
7.32
22.18

5.0
4.0
0.17
20.63
1.81
2.11

10.001
0.012
0.001
<0.001
10.001
10.001

'All P-values are I-tailed except the P value for weight m~hichis 2-tailed
'obtained from females paired with treated males. Values are for the combined treatment and posttreatment
period (4 to 23 wk).
'Values were obtained by subtracting the pretreatment means from the combined treatment and posttreatment
means (4 to 23 wk).
'7he average testosterone level was 3.41 ng/mL (SE = 0.21) for the control group and 2.15 ng/mL (SE = 0.19)
for the 20,25 diazacholesterol group during the combined treatment and posttreatment period (4 to 23 wk).
'Average weight was 181.55 g (SE = 3.36) for the control group and 168.41 g (SE = 3.74) for the 20,25
diazacholesterol group during the combined treatment and posttreatment period (4 to 23 wk).

Progesterone did not vary among birds during pretreatment, thus we compared the mean for 4 to 23 wk
among the diazacholesterol and control groups and the
mean for the priming, first boost, and second boost phases
among the AGnRH-I and control groups and among the
cRCP and control groups by using a one-tailed or twotailed ANOVA. We averaged wk 3, 4, 5, 6, 7, and 23 to
obtain mean desmosterol and nonesterified cholesterol
levels and then compared means among the diazacholesterol and control groups using a one-tailed ANOVA. We
compared mean antibody titers among the AGnRH-I and
control groups and among the cRCP and control groups
using a one-tailed ANOVA for the priming, first boost,
and second boost phases.
We subtracted the pretreatment weights of birds from
the mean of 4 to 23 wk for the diazacholesterol and control
groups and from the mean of each of the subsequent
phases for the AGnRH-I, cRCP, and control groups and
compared the differences among treatments using a twotailed ANOVA. We used PROC CORR to analyze the
correlation between average dose per individual and testosterone, progesterone, desmosterol, nonesterified cholesterol, the numbers of eggs laid, and the percentages of
eggs that hatched or were fertile for the 20,25 diazacholesterol and control groups.

RESULTS

20,25Diazacholesterol Males
The percentage of eggs that were fertile and hatched
were reduced by 20,25 diazacholesterol in treatment compared with control groups (Figure 1, Table 1).Testosterone levels decreased more in treated males than in control
males. Differences in corticosterone levels did not vary
between treatment and control males (P = 0.376). Nonesterified cholesterol levels were lower in treated males
than in control males. Desmosterol levels were greater in
treated males than in control males. Control males gained

more weight than treated males during wk 4 to 23. The
average dose of 20,25 diazacholesterol per male per day
was 59.42 mg/kg (range = 0.01 to 101.40 mg/kg). Dose
was negatively correlated with testosterone levels and
the percentage of eggs that were fertile (P = 0.0002),nonesterified cholesterol levels (P = <0.0001), and percentage
of eggs that hatched (P = 0.0015). Dose was positively
correlated with desmosterol levels (P = 0.0002).

20,25 Diazacholesterol Females
The number of eggs laid per female per week and the
percentages of eggs that were fertile and hatched were
reduced by 20,25 diazacholesterol in treatment compared
with control groups (Figure 2, Table 2). Progesterone and
nonesterified cholesterol levels were lower in treated females than in control females. Differences in corticosterone levels did not vary between treatment and control
females (P = 0.895). Desmosterol levels were higher in
treated females than in control females. Control females
gained more weight than treated females during wk 4 to
23. The average dose of 20,25 diazacholesterol per female
per day was 61.03 mg/kg (range = 1.47 to 103.37 mg/
kg). Dose was negatively correlated with progesterone
levels (P = 0.05),nonesterified cholesterol and the number
of eggs laid per female per week (P = <0.0001),the percentage of eggs that were fertile (P = 0.0458),and the percentage of eggs that hatched (P = 0.0001). Dose was positively
correlated with desmosterol (P = <0.0001).

A GnRH-I Males
The percent of eggs that were fertile did not vary between treated and control males (Table 3). The percentage
of eggs that hatched was marginally lower in the treatment compared with the control group. Changes in testosterone levels from pretreatment values did not differ
between the treated and control males during the priming
and first boost phases, but testosterone decreased more
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TABLE 2. Fertility, hormone levels, cholesterol and desmosterol levels, and weight for females treated
with 20,25 diazacholesterol and control Coturnix quail at the National Wildlife Research Center,
Fort Collins, Colorado, January to July 1997
20,25 diazacholesterol
-

x

SE

n

0.65
21.0
0.0
0.45
224.41
283.67
-0.70

0.17
11.0
0.0
0.06
26.50
29.60
1.97

19
19
19
19
19
19
19

n
Number of eggs laid
per female per week2
Percentage of fertile eggs
Percentage of eggs liatched
Progesterone (ng/mL)
Nonesterified cholesterol (jig/mL)
Desmosterol (j~g/niL)
Change in body weight (g)'

20
9
9
20
18
18
20

Control
-

x

SE

P'

1.50
70.0
36.0
0.77
161.70
32.36
20.90

0.25
5.0
4.0
0.08
44.06
3.36
3.56

<0.001
s0.001
<0.001
0.002
50.001
<0.001
0.001

'All P-values are 1-tailed except the P-value for weight, which is 2-tailed.
'Values are for the combined treatment and posttreatment period (4 to 23 w k ) .
' ~ v e r a g eweight was 204.86 g (SE = 5.27) for the control group and 184.13 (SE = 4.75) for the 20,25 diazacholesterol group for the combined treatment and posttreatment period (4 to 23 wk).

in treated males than in control males during the second
boost phase. Changes in corticosterone did not differ between treated and control males from pretreatment values
during the priming phase (P = 0.952), first boost phase
(P = 0.194), and second boost phase (P = 0.936). Changes
in body weight from pretreatment values during the 3
phases did not differ between treated and control males.
Treated males had antibody titers of 3,711 during the
priming phase, 7,789 during the first boost phase, and
9,061 during the second boost phase. Control males had
no antibody titers during all 3 phases.

A GnRH-I Females
The number of eggs laid per female per week during
all 3 phases and the percentage of eggs that were fertile

and hatched during the second boost phase did not differ
between treated and control females (Table 4). Progesterone levels did not differ between treated and control females in the priming and first boost phases, but
progesterone levels were lower in treated females than
in control females during the second boost phase.
Changes in corticosterone from pretreatment levels did
not differ between treated and control females during the
priming phase (P = 0.750), first boost phase (P = 0.257),
or second boost phase (P = 0.974).Treated females gained
more weight than control females during the priming,
first boost, and second boost phases. Treated females had
antibody titers of 2,025 during the priming phase, 8,625
during the first boost phase, and 7,275 during the second
boost phase. Control females had no antibody titers during all 3 phases.

TABLE 3. Fertility, hormone levels, and weights for males treated with AGnRH-I'
and control Coturnix quail at the National Wildlife Research Center,
Fort Collins, Colorado, January to July 1997
AGnllH-I
Parameter and phase

n

Percentage of fertile eggs7
Percentage of eggs hatched7
Change in testosterone ( ~ i g / m L )
Prime4,'
First boost",'
Second boost4,'
Change in body weight (g)
Prime',"
First boost","
Second boost","

-

Control

x

SE

n

18
18

56.0
14.0

7.0
3.0

19
19
19

-0.05
0.53
-0.38

19
19
19

18.55
28.12
30.29

x

SE

P?

20
20

62.0
24.0

7.0
5.0

0.250
0.066

0.27
0.35
0.31

20
20
20

0.09
-0.06
0.03

0.17
0.19
0.20

0.336
0.118
0.038

3.67
3.01
3.38

20
20
20

13.00
23.10
29.04

1.94
2.81
2.86

0.184
0.258
0.779

' ~ v i a ngonadotropin releasing hormone-I.
' ~ l lP-values are 1-tailed except P-values for weight and corticosterone, which are 2-tailed.
' ~ a l u e sare for 11 to 2 1 wrk and were obtained from females paired with treated males.
'Values were obtained by subtracting the pretreatment means from each of the phase means (priming, first
boost, and second boost phases).
'Average testosterone levels for the priming, first boost, and second boost phases were 3.37 ng/mL (SE =
0.19), 3.22 ng/mL (SE = 0.19), and 3.58 ng/mL (SE = 0.27), respectively, for the control group and 2.69 ng/mL
(SE = 0.29), 2.21 ng/mL (SE = 0.39), and 2.36 ng/mL (SE = 0.32), respectively, for the AGnRH-I group.
"Averdge weights for the priming, first boost, and second boost phases were 172.37 g (SE = 2.96), 182.78 g
(SE = 4.01), and 188.11 g (SE = 3.99), respectively, for the control group and 176.68 g (SE = 3.20), 187.35 g (SE =
3.41), and 190.99 g (SE = 3.91) respect~velyfor the AGnRH-I group.

YODER ET AL.
TABLE 4. Fertility, hormone levels, and weights for females treated with AGnRH-1'
and control Coturnix quail at the National Wildlife Research Center,
Fort Collins, Colorado, January to July 1997
AG~RH-I'
Parameter and phase

n

x

Control
SE

n

-

x

SE

P2

Number of eggs l a d
per female per week
Pr~me
F~rstboost
Second boost
Percentage of fert~leeggs3
Percentage of eggs hatched'
I'rogesterone (ng/mL)
Prime
First boost
Second boost
Change in body weight (g)
Prime4,'
First boost4,'
Second boost','
'Avian gonadotropin-releasing hormone-I.
' ~ l lP-values are 1-tailed except P-values for weight, which are 2-tailed
'values are for 13 to 24 wk
'values were obtained by subtracting the pretreatment means from each of the phase means (priming, first
boost, and second boost phases).
'Average weights for the priming, first boost, and second boost phases were 198.36 g (SE = 5.08), 210.85 g
(SE = 6.01), and 211.75 g (SE = 6.13), respectively, for the control group and 213.93 g (SE = 3.36), 225.82 g (SE =
5.56), and 224.68 g (SE = 6.18), respectively, for the AGnRH-I group.

cRCP Females
The proportion of eggs that were fertile and hatched
and the average stage of embryonic development at death
did not vary between treated and control birds during
the second boost phase (Table 5). The number of eggs
laid per female per week and progesterone levels did not
differ between treated and control birds during the 3
phases. Changes in body weight from pretreatment values did not vary between the treatment and control females during the 3 phases. Treated birds had higher
antibody titers of 6,658 during the priming phase, 5,059
during the first boost phase, and 8,808 during the second
boost phase. Control birds had no antibody titers during
any of the 3 phases.

DISCUSSION

20,25 Diazacholesterol
The decrease of testosterone in treated males and the
decrease in percentage of fertile eggs laid by their mates
suggests 20,25 diazacholesterol indirectly caused a reduction in spermatogenesis through lowered testosterone
le\rels, as reported by Lacombe et al. (1986, 1987) in redwinged blackbirds. Powell (1966) also observed a lower
percentage of fertile eggs laid by female Coturnix quail
paired with treated males. Wofford and Elder (1967) observed complete inhibition of reproduction for 5 to 7 mo
in pigeons fed 0.1% 20,25 diazacholesterol.
Lower levels of progesterone in 20,25 diazacholesterol
treated females likely contributed to the reduction in egg

laying (Figure 2) because progesterone is necessary for
ovulation (Johnson,2000).Powell (1966) and Wofford and
Elder (1967) noted reductions in the rate of laying by
20,25 diazacholesterol-treated female Coturnix quail and
female pigeons, respectively. One explanation may be
that preovulatory follicles in females treated with 20,25
diazacholesterol may not produce enough progesterone
and thus become atretic. Powell (1966) and Sturtevant
and Wentworth (1970) found an increase in the number
of atretic follicles in treated female Coturnix quail and
female pigeons, respectively. Sanders and Elder (1976)
observed that treated female house sparrows did not have
mature follicles in the ovary.
We expected 20,25 diazacholesterol to reduce corticosterone levels because it is a steroid hormone. We recognize that corticosterone is difficult to accurately measure
in the plasma because the stress of handling increases the
levels. The rise in corticosterone due to handling was not
of concern here but rather a marked decrease in corticosterone levels, which would indicate that 20,25 diazacholesterol impaired corticosterone production. However,
because corticosterone levels were similar in treatment
and control groups, it is possible that a larger dose of
20,25 diazacholesterol is needed to affect this hormone.
Corticosterone occurs at higher levels than reproductive
hormones and thus may not be as sensitive to treatment.
Another possibility is that 20,25 diazacholesterol may be
preferentially deposited in reproductive tissues rather
than in adrenal tissue. Based on these results, it seems
unlikely that treatment at suggested levels will negatively
affect corticosterone, which is a stress hormone involved
in the fight-or-flight response.
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TABLE 5. Fertility, stage of embryonic development at death, hormone levels, and weights
for females treated with CRCP' and control Cotumix quail at the National
Wildlife Research Center, Fort Collins, Colorado, January to July 1997
cRCP
Parameter and phase

n

Percentage of fertile eggs7
Percentage of eggs hatched"
Number of eggs laid
per female per week
Prime
First boost
Second boost
A~reragestage of embrvonic
development at deathi'
Progesteroi~e(ng/mL)
Prime
First boost
Second boost
Change in body weight (g)
prime4,'
First b o o ~ t ~ , ~
Second boost4.'

17
17

-

Control

x

SE

n

70.0
14.0

5.0
4.0

15
15

-

x

SE

P'

59.0
17.0

7.0
3.0

0.188
0.708

20
19
18

5.57
4.92
4.50

0.21
0.25
0.27

19
17
15

5.00
4.32
4.43

0.28
0.35
0.17

0.117
0.168
0.826

17

1.22

0.20

15

1.63

0.25

0.106

20
18
18

0.80
0.67
0.79

0.16
0.14
0.11

19
16
15

0.72
0.76
0.81

0.10
0.09
0.08

0.678
0.585
0.854

20
19
18

24.44
32.98
33.80

3.91
3.69
4.73

19
16
15

14.41
28.70
29.42

3.12
4.22
4.20

0.054
0.510
0.502

'Chicken riboflavin carrier protein.
he P-values for weight, progesterone, number of eggs laid, and percentage of fertile eggs are 2-tailed. The
P-values for the percentage of eggs hatched and average stage of embryonic development are 1-tailed.
' ~ a l u e sare for 14 to 24 wk.
'Values were obtained by subtracting the pretreatment means from each of the phase means (priming, first
boost, and second boost phases).
'Average weights for the priming, first boost, and second boost phases were 198.36 g (SE = 5.08), 210.85 g
(SE = 6.01), and 21 1.75 g (SE = 6.13), respectively, for the control group and 207.28 g (SE = 3.59), 215.77 g (SE =
1.33), and 217.35 g (SE = 1.59), respectively, for the cRCP group.

The increase in desmosterol while nonesterified cholesterol decreased in treated birds indicated that 20,25 diazacholesterol may act as an antagonist to the ~ ~ ' - r e d u c t a s e
enzyme, which converts desmosterol to cholesterol, as
suggested by Dietert and Scallen (1969) and Emmons et
al. (1982). However, 20,25 diazacholesterol also may act
as an antagonist to the cytochrome P450 enzyme, causing
an inhibition of the side chain cleavage. Counsel1 et al.
(1971) suggested that inhibition of side chain cleavage
might be caused by the substitution of a nitrogen for C-25.
We observed signs of toxicity, such as listlessness,
weight loss, difficulty breathing, and loss of muscle control in some of the 20,25 diazacholesterol-treated birds.
Eight of 20 treated females and 4 of 20 treated males died
by wk 9, and the cause of death was suspected to be
toxic effects of 20,25 diazacholesterol. Only 4 of 20 control
females and 1of 20 control males died by wk 9. Necropsies
of treated birds indicated liver damage such as fatty livers
and friable livers. Elder (1964), Powell (1966), Woulfe
(1967), and Sturtevant and Wentworth (1970) also observed mortality and toxic effects on quail and pigeons
treated with 20,25 diazacholesterol. Because cholesterol is
an integral component of cell wall structure, the reduced
cholesterol may cause toxicity. Ashraf et al. (1984) suggested that the increased desmosterol levels may contribute to an increase in membrane fluidity. Reddy et al.
(1982) found that 20,25 diazacholesterol has a direct effect
on muscle fibers, changing them morphologically and
biochemically, and causes myotonia. We speculate that
20,25 diazacholesterol may cause cytotoxicity to hepato-

cytes when it is stored in the liver. The level of mortality
observed in this study is a concern and highlights the
need to perform dose-response studies. Other studies on
red-winged blackbirds (Lacombe et al., 1986) and house
sparrows (Mitchell et al., 1979)did not show such mortality. Feeding for a shorter period of time or lowering the
dose may give satisfactory results without causing mortality.
Further analysis showed that birds treated with 20,25
diazacholesterol lost weight during the treatment period.
Treated birds consumed less feed during the treatment
period because the bait apparently was unpalatable,
which contributed to weight loss and less weight gain
overall. Upon removal of the treated bait, birds in the
treatment group gained weight, and the differences in
weight were not significant between female groups after
wk 10 and between male groups after wk 11. Reduced
consumption of 20,25 diazacholesterol treated bait and
subsequent weight loss also was noted by Powell (1966)
and Lacombe et al. (1987).Lacombe et al. (1987) suggested
that 20,25 diazacholesterol may affect the metabolism of
birds, contributing in part to weight loss. Although we
cannot exclude the possibility that weight loss caused
ovarian regression, we felt the weight loss was not the
cause of the reduction in egg laying and fertility because
they continued to be suppressed for 15 wk after birds
gained weight. Weight loss only constituted a 10%)loss
in the treatment groups.
Dose-response work should be conducted on wild species of interest before 20,25 diazacholesterol is tested in the
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field to determine an effective and nontoxic dose for each
species. These lab tests should include a gavage study in
which precise doses are known. Desmosterol and nonesterified cholesterol can be used as markers of efficacy in the
absence of breeding by wild species in a laboratory setting.
Dose and plasma values of desmosterol and nonesterified
cholesterol can then be correlated, and this information can
be extrapolated to determine dose when 20,25 diazacholesterol is fed ad libitum. Because we could not measure 20,25
diazacholesterol in the plasma of treated birds, even though
it can be measured in spiked control plasma samples, a
specific assay to measure plasma levels of 20,25 diazacholesterol metabolites is also needed. Because a daily dosing regimen is required, development of a more practical
method of delivery that allows for a prolonged release of
20,25 diazacholesterol in a single dose would be advantageous. Nontarget and secondary hazards will also need to
be assessed prior to wide scale use.

lmmunocontraceptives
The reduced testosterone levels of AGnRH-I-treated
males during the second boost phase likely was not biologically significant because fertility of treated males was not
affected, and hatchability was only marginally decreased.
Several investigators obtained lowered testosterone levels,
reduced fertility, and reduced libido after vaccinating
against GnRH in male cattle (Robertson et al., 1982), rats
(Ladd et al., 1989), male piglets (Meloen et al., 1994), and
brown-headed cowbirds (Thompson et al., 1994).On average, the AGnRH-I antibody titers produced in this study
likely were not sufficient to reduce testosterone levels
enough to reduce reproduction. However, 3 of the 20 birds
responded to the AGnRH-I vaccine by producing antibody
titers during the second boost phase ranging from 1:32,000
to 1:128,000, which reduced testosterone to 0 to 3.6 ng/mL
and reduced fertility for 5 to 12 wk. The failure of the
vaccine to produce high antibody titers in the majority of
the birds may be due to the vaccine being metabolized too
quickly. The vaccine depot must be present for several
weeks for good antibody production. A route of administration other than subcutaneous vaccination may prevent
the depot from being metabolized too quickly. The overall
health of the animal may also affect the immune response.
However, poor health would also tend to decrease fertility
and egg production, which was not observed in this study
and therefore was not a likely explanation for the vaccine failure.
Lower progesterone levels in AGnRH-I-treated females
during the second boost phase likely were not biologically
significant because egg laying was not reduced. On average, the AGnRH-I antibody titers produced in this study
likely were not h g h enough to reduce progesterone levels
due to the reasons mentioned above. Esbenshade and Britt
(1985) found that progesterone and estradiol levels decreased to basal levels, and acyclicity occurred in gilts vaccinated against GnRH. In our experiment, 2 females had
higher-than-average titers of 1:24,000 and 1:12,000 during
the second boost phase. These birds did not lay eggs for

5 and 2 wk, respectively, and had progesterone levels ranging from 0 to 0.41 ng/mL. Control birds did not have
antibody titers, and egg production was normal.
Although the exact cause is unknown, the higher weight
gain of the AGnRH-I-treated females during the study may
be due to a reduction in estradiol levels. We did not measure estradiol in our study; therefore, it is unclear if t h s
was the case. Because GnRH affects FSH and LH, it is
reasonable to expect vaccination against GnRH to lower
estradiol levels. Because estradiol is the hormone responsible for sexual behavior in birds (Bell and Freeman, 1971),
AGnRH-I-treated females might not have exhibited sufficient behavioral cues to elicit sexual behavior from the
male. As a result, females might have been chased less
by males, and more time might have been spent feeding,
resulting in increased weight gain.
Similarly, low antibody titers and a lack of reduced
hatchability with the cRCP vaccination indicate that the
antibody titers generated were not high enough to have
an effect. Vaccination against cRCP likely will not affect
breeding behavior because it does not affect the reproductive hormones. Seshagiri and Adiga (1987)found that vaccination against cRCP in bonnet monkeys (Macaca vndiata)
did not alter estrogen and progesterone levels.

Management Implications
Of the 3 contraceptives investigated, 20,25 diazacholesterol gave the most promising results. It was efficacious for
both sexes and reduced egg production and hatchability.
Because 20,25 diazacholesterol is effective for 2 2 mo in
Coturnix quail and is reversible, it is a promising contraceptive for field use. However, additional dose-response work
will need to be conducted on 20,25 diazacholesterol to
minimize the risk of birds receiving a toxic dose. Because
the level of 20,25 diazacholesterol that causes toxicity will
vary by species, lab tests will need to be conducted to
establish appropriate dosages. It may be necessary to use
desmosterol and nonesterified cholesterol as markers because many of the species of interest will not breed in a
laboratory setting.
An advantage of the AGnRH-I vaccine is that it can
potentially contracept both sexes. The potential length of
efficacy of the AGnRH-I vaccine, and its reversibility, make
it another promising field contraceptive. Although the
overall results did not show an effect, it is clear from the
few responders in the male and female treated groups that
this vaccine has potential to work. Further research should
be done on finding the best vaccination protocol to maximize antibody titers. This vaccination protocol should also
be tested with cRCP to determine if the failure of the vaccine
was due to the vaccine or the vaccination protocol. In order
to be practical for field use, an oral vaccine or other method
of delil~erythat does not require capture of birds (such as
intradermal) will need to be developed.
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